F A Whitlock, J Price. Show Affiliations »
Abstract
Mesh: See more » Adrenergic alpha-Antagonists/pharmacologyAdrenergic beta-Antagonists/pharmacologyAdrenergic beta-Antagonists/therapeutic useAlcoholism/drug therapyAnxiety/drug therapyChlordiazepoxide/therapeutic useDiazepam/therapeutic useHumansHyperventilation/drug therapyMental Disorders/drug therapyOxprenolol/therapeutic usePropranolol/adverse effectsPropranolol/therapeutic useSchizophrenia/drug therapySotalol/therapeutic useSubstance Withdrawal Syndrome/drug therapySubstance-Related Disorders/drug therapySympathetic Nervous System/drug effectsTremor/drug therapy
Substances: See more » Adrenergic alpha-AntagonistsAdrenergic beta-AntagonistsOxprenololChlordiazepoxidePropranololSotalolDiazepam
Year: 1974 PMID: 4154835 DOI: 10.2165/00003495-197408020-00004
Source DB: PubMed Journal: Drugs ISSN: 0012-6667 Impact factor: 9.546